QuidelOrtho Announces $300 Million Share Repurchase Authorization
It also demonstrates our commitment to strategically return capital to shareholders, while investing in the long-term growth of the business.
- It also demonstrates our commitment to strategically return capital to shareholders, while investing in the long-term growth of the business.
- The share repurchase authorization permits QuidelOrtho to repurchase, on a discretionary basis, up to $300 million of its outstanding shares of common stock in the open market or in privately negotiated transactions, subject to market conditions and other factors.
- This share repurchase authorization does not obligate QuidelOrtho to repurchase any specific number of shares and may be suspended, modified, or terminated at any time without prior notice.
- All forward-looking statements are based on information currently available to QuidelOrtho and speak only as of the date hereof.